Literature DB >> 30189093

Liberal Acceptance Bias, Momentary Aberrant Salience, and Psychosis: An Experimental Experience Sampling Study.

Ulrich Reininghaus1,2,3, Margaret Oorschot2, Steffen Moritz4, Charlotte Gayer-Anderson3, Matthew J Kempton5, Lucia Valmaggia6,7, Philip McGuire5,7, Robin Murray5,7, Philippa Garety6,7, Til Wykes5,7, Craig Morgan3,7, Inez Myin-Germeys8.   

Abstract

Cognitive models of psychosis posit that reasoning biases are an important mechanism contributing to the formation of psychotic symptoms, in part through transforming anomalous experiences of aberrant salience into frank psychotic symptoms. This study aimed to investigate the interplay of liberal acceptance (LA) bias, which is a specific type of reasoning bias, and momentary aberrant salience in the development of paranoid and psychotic experiences in daily life in first-episode psychosis patients (FEP), at-risk mental state participants (ARMS), and controls. We used a novel experimental Experience Sampling Methodology (eESM) task for measuring LA bias (ie, decisions based on low probability estimates) and ESM measures of momentary aberrant salience and paranoid and psychotic experiences in 51 FEP, 46 ARMS, and 53 controls. We found evidence that LA bias was more likely to occur in FEP than in controls. Further, LA bias was associated with psychotic and paranoid experiences (all P < .007) and modified the association between momentary aberrant salience and psychotic experiences (χ2(df) = 7.4(2), P = .025) in ARMS, such that momentary salience was associated with more intense psychotic experiences in the presence of LA bias in ARMS, but not in FEP and controls. Our findings suggest that LA bias may be central for anomalous experiences such as momentary aberrant salience to increase intensity of psychotic experiences in at-risk individuals. Further, LA bias appears to be more likely to be present, but not directly linked to current intensity of psychotic experiences, in treated FEP. Novel eESM tasks open new avenues for targeting psychological processes under real-world conditions.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  aberrant salience; experimental experience sampling methodology; first-episode psychosis; prodrome; reasoning bias

Year:  2019        PMID: 30189093      PMCID: PMC6581124          DOI: 10.1093/schbul/sby116

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  Reasoning, emotions, and delusional conviction in psychosis.

Authors:  Philippa A Garety; Daniel Freeman; Suzanne Jolley; Graham Dunn; Paul E Bebbington; David G Fowler; Elizabeth Kuipers; Robert Dudley
Journal:  J Abnorm Psychol       Date:  2005-08

2.  Probabilistic judgements in deluded and non-deluded subjects.

Authors:  S F Huq; P A Garety; D R Hemsley
Journal:  Q J Exp Psychol A       Date:  1988-11

3.  Incautious reasoning as a pathogenetic factor for the development of psychotic symptoms in schizophrenia.

Authors:  Steffen Moritz; Todd S Woodward; Daniel Hausmann
Journal:  Schizophr Bull       Date:  2005-12-09       Impact factor: 9.306

4.  Memory and metamemory in schizophrenia: a liberal acceptance account of psychosis.

Authors:  S Moritz; T S Woodward; L Jelinek; R Klinge
Journal:  Psychol Med       Date:  2008-01-21       Impact factor: 7.723

5.  Semantic expectations can induce false perceptions in hallucination-prone individuals.

Authors:  Ans Vercammen; André Aleman
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

6.  Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial.

Authors:  Philippa A Garety; David G Fowler; Daniel Freeman; Paul Bebbington; Graham Dunn; Elizabeth Kuipers
Journal:  Br J Psychiatry       Date:  2008-06       Impact factor: 9.319

7.  Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population.

Authors:  Ralph E Hoffman; Scott W Woods; Keith A Hawkins; Brian Pittman; Mauricio Tohen; Adrian Preda; Alan Breier; Jill Glist; Jean Addington; Diana O Perkins; Thomas H McGlashan
Journal:  Br J Psychiatry       Date:  2007-10       Impact factor: 9.319

8.  The Psychosis Continuum: Testing a Bifactor Model of Psychosis in a General Population Sample.

Authors:  Mark Shevlin; Eoin McElroy; Richard P Bentall; Ulrich Reininghaus; Jamie Murphy
Journal:  Schizophr Bull       Date:  2016-05-24       Impact factor: 9.306

9.  Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study.

Authors:  Ulrich Reininghaus; Matthew J Kempton; Lucia Valmaggia; Tom K J Craig; Philippa Garety; Adanna Onyejiaka; Charlotte Gayer-Anderson; Suzanne H So; Kathryn Hubbard; Stephanie Beards; Paola Dazzan; Carmine Pariante; Valeria Mondelli; Helen L Fisher; John G Mills; Wolfgang Viechtbauer; Philip McGuire; Jim van Os; Robin M Murray; Til Wykes; Inez Myin-Germeys; Craig Morgan
Journal:  Schizophr Bull       Date:  2016-02-01       Impact factor: 9.306

Review 10.  From prediction error to psychosis: ketamine as a pharmacological model of delusions.

Authors:  P R Corlett; G D Honey; P C Fletcher
Journal:  J Psychopharmacol       Date:  2007-05       Impact factor: 4.153

View more
  2 in total

1.  Recurrent Neural Networks in Mobile Sampling and Intervention.

Authors:  Georgia Koppe; Sinan Guloksuz; Ulrich Reininghaus; Daniel Durstewitz
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

2.  Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.

Authors:  Ulrich Reininghaus; Annelie Klippel; Henrietta Steinhart; Thomas Vaessen; Martine van Nierop; Wolfgang Viechtbauer; Tim Batink; Zuzana Kasanova; Evelyne van Aubel; Ruud van Winkel; Machteld Marcelis; Therese van Amelsvoort; Mark van der Gaag; Lieuwe de Haan; Inez Myin-Germeys
Journal:  Trials       Date:  2019-12-26       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.